Skip to main content
Caplight Logo









A-SEEDS Co., Ltd.

A-SEEDS Co., Ltd.

Private
MatsumotoHealthcare & Life Scienceshttps://www.a-seeds.co.jp/

Last Round

Series A

Jul 7, 2025

Total Funding Raised

$18.04M

Company Overview

A-SEEDS Co., Ltd. is a biotechnology company that researches and develops next-generation CAR-T cell therapies using non-viral genetic engineering platforms for the treatment of solid tumors and hematologic malignancies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T cell therapynon-viral gene therapycell therapysolid tumor treatmentgene-modified immune cellsbiotechnologyclinical trialscontract development and manufacturing organizationCDMOprecision medicinenext-gen CAR-Tcancer immunotherapypiggyBac transposondrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

A-SEEDS Co., Ltd. Comparables

Compare A-SEEDS Co., Ltd. with similar companies based on industry and business-model similarity.

A-SEEDS Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
T-CURX GmbH
83%
T Cell Nouveau Inc.
82%
Noile-Immune Biotech
81%

A-SEEDS Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 7, 2025
SeedJan 4, 2024

Key People

Founding team and executive leadership

Shigeki Yagyu

Chief Executive Officer

Executive Team

Kiyohito Tani

Chief Operating Officer

Executive Team

A-SEEDS Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2025

    $15M round led by Delight Ventures and Mizuho Capital.

  • Jan 4, 2024

    Raised $3M with Hachijuni Investment Co., Ltd. participating.

A-SEEDS Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

A-SEEDS Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about A-SEEDS Co., Ltd.'s valuation, stock price, and market status.

Is A-SEEDS Co., Ltd. a public or private company?

A-SEEDS Co., Ltd. is a private company.

What is the current stock price of A-SEEDS Co., Ltd.?

A-SEEDS Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is A-SEEDS Co., Ltd. worth (valuation)?

Valuation information for A-SEEDS Co., Ltd. is not publicly available.

Can I buy A-SEEDS Co., Ltd. stock?

A-SEEDS Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was A-SEEDS Co., Ltd.'s last funding round?

A-SEEDS Co., Ltd.'s most recent funding round was Series A on July 7, 2025.

Who are the main investors in A-SEEDS Co., Ltd.?

Key investors in A-SEEDS Co., Ltd. include Mizuho Capital, Delight Ventures.

Will A-SEEDS Co., Ltd. IPO soon?

No public IPO plans have been announced for A-SEEDS Co., Ltd..

How can I track A-SEEDS Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor A-SEEDS Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMatsumoto
Employee Range5
Year Founded2020
Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?